Loading...
XNAS
XOMAP
Market cap320mUSD
Dec 04, Last price  
26.68USD
1D
0.26%
1Q
-0.30%
Name

XOMA Corp

Chart & Performance

D1W1MN
XNAS:XOMAP chart
P/E
—
P/S
11.23
EPS
—
Div Yield, %
8.08%
Shrs. gr., 5y
5.95%
Rev. gr., 5y
9.17%
Revenues
28m
+498.72%
18,669,00029,498,00084,252,00067,987,00098,430,00033,641,00058,196,00033,782,00035,451,00018,866,00055,447,0005,564,00052,690,0005,299,00018,370,00029,385,00038,160,0006,027,0004,758,00028,487,000
Net income
-14m
L-66.15%
2,779,000-51,841,000-12,326,000-45,245,000550,000-68,756,000-32,743,000-71,065,000-124,058,000-38,301,000-20,606,000-53,530,00014,596,000-13,343,000-7,698,00013,298,00015,798,000-17,104,000-40,831,000-13,821,000
CFO
-14m
L-24.29%
-44,190,000-33,270,0004,543,000-32,975,0007,435,000-52,537,000-29,062,000-40,765,000-45,915,000-78,282,000-30,892,000-33,689,0002,686,000-12,644,000-285,00010,092,00022,678,000-12,879,000-18,158,000-13,748,000
Dividend
Oct 03, 20240.53906 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
URL
https://www.xoma.com/
IPO date
Jun 06, 1986
Employees
11
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT